February 11th, 2021 – Toronto, Ontario – American Aires Inc. (CSE: WIFI) (the “Company” or “Aires“) a nanotechnology-focused disruptor focused on developing products that reduce the harmful effects of electromagnetic radiation (“EMR”) emitted by everyday consumer electronic devices, is pleased to announce preliminary unaudited financial results for the fourth quarter ending December 31, 2020 (“Q4” or “Q4 2020”). Aires recorded an increase in revenue of over 300% in the fourth quarter relative to the same period the prior year based on preliminary and unaudited numbers.
Key Highlights:
- Year-over-year Revenue Expansion: Relative to the fourth quarter of 2019 which recorded sales of $216 thousand, Q4 2020 revenue increased by more than 300%, driven by the Company’s successful efforts to attract new customers following enhanced marketing efforts and the launch of its new Lifetune product line.
- High Gross Margins Underpin Business Model: Preliminary and estimated gross margins (unaudited) were consistent with historical averages of approximately 70% during the period, demonstrating the strength of Aires’ business model, its ability to control costs and the potential to drive long-term positive cash flows.
- 5G Optimized Product Line Unveiled: During the quarter, Aires announced the launch of Lifetune, a revolutionary new line of EMR protection products that are optimized for, and compatible with, the most advanced telecommunications technology, including the latest generation, 5G, as well as all previous generations.
- Positioned for Growth. The Company launched an enhanced web site in Q4 2020, which includes a streamlined e-commerce and sales platform that will enable Aires to support meaningful and scalable growth while maintaining a lean employee base.
“We are thrilled that our Q4 2020 results exceeded our expectations and that efforts during the quarter positioned us strongly to generate further growth with robust margins,” said Dimitry Serov, President and CEO of Aires. “We have now turned our focus to increased global marketing strategies and promoting our new product line, Lifetune, which is designed to specifically address the global health concerns associated with increased EMR emitted from 5G technology. As 5G networks expand around the world, we are seeing increased reports from leading health organizations and news headlines discussing the potential harm of EMR and the importance of identifying solutions to reduce these harmful effects. I am proud to share that Aires products are that solution.”
The Company recently launched a full suite of consumer products under the brand name ‘Lifetune’, which is a key milestone for Aires. Lifetune represents the only known product line currently available to specifically address the global health concerns associated with increased EMR emitted by the latest generation 5G technology (and all previous generations), as well as other data-transmitting electronics, such as cell phones, cordless phones, wireless earpieces, wireless headsets, computers, laptops, monitors, smart TVs, Wi-Fi routers and even baby monitors, to name a few. In concert with this new product launch, Aires has adopted a global ecommerce and distribution platform that can easily scale with sales growth.
Since its inception in 2019, Aires has realized steady growth and has been aggressively building out its ecommerce platform which is now capable of delivering up to 1,000 shipments per day. These distribution capabilities are supported by newly-added customer service center agreements as well as strategically placed fulfillment centers that can ensure prompt delivery around the world. With a daily average of over 100 transactions, and an average value per purchase of approximately $300, Aires is strongly positioned to continue growing sales, driving financial performance and generating value for shareholders.
About American Aires Inc.
American Aires Inc. is Canadian-based nanotechnology company which has developed proprietary silicon-based Aires silicon resonator chips that reduce the harmful effects of electromagnetic radiation (EMR). The technology was developed by a team of highly credited scientists and confirmed by independent third-party validation including peer reviewed studies and publications in scientific journals. Aires’ Lifetune products specifically target EMR emitted by consumer electronic devices such as cellphones, computers, baby monitors, Wi-Fi radiation, including the rapidly expanding next-generation high-speed 5G networks. Aires is listed on the CSE under ticker ‘WIFI’.
On behalf of the board of directors
Company Contact
Dimitry Serov, CEO
Email: dimitry@airestech.com
Phone: (905) 482-4667
Website: www.airestech.com
For further information please contact:
Investor Cubed Inc.
Neil Simon, CEO
Email: wifi@airestech.com
Phone: (647) 258-3310
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, jointventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management’s current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “predicts”, “intends”, “targets”, “aims”, “anticipates” or “believes” or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Certain material assumptions regarding such forward-looking statements may be discussed in this news release and the Company’s annual and quarterly management’s discussion and analysis filed at www.sedar.com. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.
No securities regulatory authority has either approved or disapproved of the contents of this news release. The Shares have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States, or to or for the account or benefit of any person in the United States, absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any common shares in the United States, or in any other jurisdiction in which such offer, solicitation or sale would be unlawful. We seek safe harbour.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Not intended for distribution to United States Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of United States Securities laws.
